Long-term mortality risk low after cerebral vein thrombosis

July 12, 2012
Long-term mortality risk low after cerebral vein thrombosis
For patients who survive a cerebral vein thrombosis, the long-term risk of mortality and recurrent venous thromboembolism seems to be low, according to a study published in the July issue of the Journal of Thrombosis and Haemostasis.

(HealthDay) -- For patients who survive a cerebral vein thrombosis (CVT), the long-term risk of mortality and recurrent venous thromboembolism (VTE) seems to be low, according to a study published in the July issue of the Journal of Thrombosis and Haemostasis.

Francesco Dentali, M.D., from the University of Insubria in Varese, Italy, and colleagues retrospectively assessed long-term , residual disability, and recurrent VTE in an international cohort of 706 patients (73.7 percent female) with a first CVT episode who were followed for a median of 40 months (range, six to 297 months).

Over the follow-up period, the researchers found that 2.8 percent of patients died, 89.1 percent had a complete recovery (modified Rankin Score [mRS], 0 to 1), and 3.8 percent had a partial recovery and were independent (mRS, 2). The mean treatment duration was 12 months, during which time 84 percent of patients were treated with oral anticoagulants. CVT recurred in 4.4 percent of patients, and 6.5 percent had VTE in a different site, corresponding with an overall incidence of recurrence of 23.6 events per 1,000 patient-years and of 35.1 events per 1,000 patient years after anticoagulant therapy withdrawal. The only significant predictor of in multivariate analysis was a previous VTE (hazard ratio, 2.70).

"The long-term risk of mortality and recurrent VTE appears to be low in patients who survived the acute phase of CVT," the authors write.

Explore further: Higher risk of VTE in CKD surgical patients on enoxaparin

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Higher risk of VTE in CKD surgical patients on enoxaparin

June 8, 2012

(HealthDay) -- For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is significantly higher in those treated with enoxaparin compared to those ...

Venous thromboembolism up in adult hospitalizations

June 8, 2012

(HealthDay) -- Every year, more than half a million hospitalized U.S. adults acquire venous thromboembolism (VTE), a growing public health concern that is often preventable, according to research published in the June 8 issue ...

Recommended for you

Researchers discover rare flu-thwarting mutation

September 29, 2016

A rare and improbable mutation in a protein encoded by an influenza virus renders the virus defenseless against the body's immune system. This University of Rochester Medical Center discovery could provide a new strategy ...

Utah man may have contracted Zika from dying father's tears

September 29, 2016

A Utah man who mysteriously contracted Zika from his infected father may have got it by touching his dad's tears or sweat with his bare hands, according to new research unveiled Wednesday that found the unusual transmission ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.